Pharmacological characterization of novel A3 adenosine receptor-selective antagonists
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 36 (9) , 1157-1165
- https://doi.org/10.1016/s0028-3908(97)00104-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Structure−Activity Relationships of 4-(Phenylethynyl)-6-phenyl-1,4- dihydropyridines as Highly Selective A3 Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1997
- Susceptibility to Immunologically Mediated Fatigue in C57BL/6 versus Balb/c MiceClinical Immunology and Immunopathology, 1996
- Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor AgonistsBiochemical and Biophysical Research Communications, 1996
- 6-Phenyl-1,4-dihydropyridine Derivatives as Potent and Selective A3 Adenosine Receptor AntagonistsJournal of Medicinal Chemistry, 1996
- Interaction of 1,4-Dihydropyridine and Pyridine Derivatives with Adenosine Receptors: Selectivity for A3 ReceptorsJournal of Medicinal Chemistry, 1996
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) Are Selective for the Human A3Receptor SubtypeJournal of Medicinal Chemistry, 1996
- Interactions of Flavonoids and Other Phytochemicals with Adenosine ReceptorsJournal of Medicinal Chemistry, 1996
- Adenosine A3 receptors in mast cellsTrends in Pharmacological Sciences, 1994
- (E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonistsJournal of Medicinal Chemistry, 1992
- Selective A1-Antagonists for Treatment of Cognitive DeficitsNucleosides and Nucleotides, 1991